Real‐world prognostic factors for survival among treated patients with metastatic pancreatic ductal adenocarcinoma

Abstract Background Many real‐world studies of patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) are restricted to single centers, limiting the generalizability of their insights. This study aimed to identify important population‐based predictors for survival in patients diagnosed wi...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Kenneth H. Yu, Muhammet Ozer, Paul Cockrum, Andy Surinach, Shu Wang, Bong Chul Chu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2021-12-01
coleção:	Cancer Medicine
Assuntos:	antineoplastic agents electronic health records pancreatic ductal adenocarcinoma prognostic factors real‐world evidence treatment options
Acesso em linha:	https://doi.org/10.1002/cam4.4415
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!